The cell-grown fish from Wildtype, which will be available in a fine-dining restaurant, marks the first time cultivated ...

DermaSensor today announced the publication of two pivotal studies validating its device for skin cancer detection in primary ...

Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ('Thiogenesis' or the 'Company') a clinical-stage biotechnology company developing disulfides that drive the production of intracellular ...

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...

Exoskeleton developer Wandercraft has raised $75 million in new financing, shortly after inking a strategic partnership with ...

Merck (MRK) stock is in focus as its Enflonsia RSV shot is cleared for infants in the U.S. in a market led by Sanofi (SNY) ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $149.5, with a ...

Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions, according to a June 12 news release. THe FDA’s 510(k) clearance was based on safety testing ...